Berberine Hydrochloride
Berberine Hydrochloride is a pharmaceutical drug with 8 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
4
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
50.0%
2 of 4 finished
50.0%
2 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effects of Berberine on the Human Gut Microbiome
Efficacy and Safety of Berberine for Gastric Intestinal Metaplasia
6-year Follow-up Data After the Berberine Intervention Trial
A Research of Berberine Hydrochloride to Prevent Colorectal Adenomas in Patients With Previous Colorectal Cancer
Effect of Berberine Hydrochloride on Blood Pressure and Vascular Endothelial Function in Patients With Hypertension
Clinical Trials (8)
Effects of Berberine on the Human Gut Microbiome
Efficacy and Safety of Berberine for Gastric Intestinal Metaplasia
6-year Follow-up Data After the Berberine Intervention Trial
A Research of Berberine Hydrochloride to Prevent Colorectal Adenomas in Patients With Previous Colorectal Cancer
Effect of Berberine Hydrochloride on Blood Pressure and Vascular Endothelial Function in Patients With Hypertension
Study of Berberine Hydrochloride in Prevention of Colorectal Adenomas Recurrence
Effects of Berberine Hydrochloride and Bifidobacterium in Prediabetes Prevention and Treatment
Effects of Berberine Hydrochloride and Bifidobacterium in Diabetes Mellitus Prevention and Treatment
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8